Recursion Pharmaceuticals, Inc. · NASDAQ:RXRX

Khan Najat had 85,815 Recursion Pharmaceuticals, Inc. shares withheld for tax (Form 4)

Traded Nov 16, 2026 · Filed Nov 18, 2026

On Nov 16, 2026, Khan Najat (Director, CEO and President) had 85,815 Recursion Pharmaceuticals, Inc. shares withheld for tax at US$3.19 for US$273K, leaving 1,987,075 shares. Filed Nov 18, 2026 (Form 4).

Withheld for tax
85,815 shares
Price
US$3.19
Value
US$273K
Holding after
1,987,075 shares
Trading plan
No
Role
Director, CEO and President

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 16, 2026Class A Common StockShares withheld for tax85,815US$3.191,987,075Direct

Source

Download original · View original at SEC

Related